EPCAM and pancreatic neoplasm: Surprisingly, we found cells that displayed both CD163 and EpCAM immunofluorescence in blood from patients with a variety of types of patients (Figure 1A-1E), including breast, cervical, ovarian, endometrial and pancreatic cancer, but not in healthy subjects (Figure 1F).